(CHKP) Check Point Software - Ratings and Ratios
Firewall, CloudGuard, Harmony, ThreatCloud, Infinity
EPS (Earnings per Share)
Revenue
Dividends
Currently no dividends paid| Risk via 5d forecast | |
|---|---|
| Volatility | 23.4% |
| Value at Risk 5%th | 35.6% |
| Relative Tail Risk | -7.67% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.18 |
| Alpha | -6.79 |
| CAGR/Max DD | 0.64 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.459 |
| Beta | 0.583 |
| Beta Downside | 0.502 |
| Drawdowns 3y | |
|---|---|
| Max DD | 22.59% |
| Mean DD | 6.13% |
| Median DD | 4.33% |
Description: CHKP Check Point Software December 19, 2025
Check Point Software Technologies Ltd. (NASDAQ: CHKP) delivers a layered security portfolio that protects enterprises across cloud, network, mobile, endpoint, and IoT environments. Its flagship offerings include on-premises hyperscale AI-driven threat prevention, the CloudGuard suite for cloud-native security, the Harmony workspace protection platform, and the Infinity platform that unifies prevention, response, and automation with ThreatCloud AI and a generative-AI copilot. The company also provides managed detection and response, incident-response consulting, and professional services to design, implement, and optimize its solutions.
Key data points (FY 2023): revenue of roughly $2.7 billion, with subscription and SaaS revenue representing about 80 % of total and operating margins near 70 %. The cybersecurity market is projected to expand at a 10 % compound annual growth rate through 2029, driven by accelerating cloud migration, rising ransomware incidents, and increasing enterprise adoption of AI-enhanced defenses-trends that directly benefit Check Point’s hyperscale and AI-centric product lines.
For a deeper quantitative assessment, you may want to explore ValueRay’s detailed financial models for CHKP.
Piotroski VR‑10 (Strict, 0-10) 6.5
| Net Income (1.01b TTM) > 0 and > 6% of Revenue (6% = 161.1m TTM) |
| FCFTA 0.21 (>2.0%) and ΔFCFTA 2.06pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 11.87% (prev 9.35%; Δ 2.52pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.21 (>3.0%) and CFO 1.21b > Net Income 1.01b (YES >=105%, WARN >=100%) |
| Net Debt (-619.9m) to EBITDA (1.00b) ratio: -0.62 <= 3.0 (WARN <= 3.5) |
| Current Ratio 1.19 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (109.5m) change vs 12m ago -3.44% (target <= -2.0% for YES) |
| Gross Margin 85.97% (prev 87.70%; Δ -1.74pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 47.88% (prev 45.80%; Δ 2.08pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 505.4 (EBITDA TTM 1.00b / Interest Expense TTM 1.80m) >= 6 (WARN >= 3) |
Altman Z'' 15.83
| (A) 0.06 = (Total Current Assets 2.03b - Total Current Liabilities 1.71b) / Total Assets 5.70b |
| (B) 2.59 = Retained Earnings (Balance) 14.77b / Total Assets 5.70b |
| warn (B) unusual magnitude: 2.59 — check mapping/units |
| (C) 0.16 = EBIT TTM 909.7m / Avg Total Assets 5.61b |
| (D) 5.65 = Book Value of Equity 14.80b / Total Liabilities 2.62b |
| Total Rating: 15.83 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 91.62
| 1. Piotroski 6.50pt |
| 2. FCF Yield 6.55% |
| 3. FCF Margin 43.91% |
| 4. Debt/Equity 0.01 |
| 5. Debt/Ebitda -0.62 |
| 6. ROIC - WACC (= 19.59)% |
| 7. RoE 35.27% |
| 8. Rev. Trend 78.00% |
| 9. EPS Trend 69.90% |
What is the price of CHKP shares?
Over the past week, the price has changed by +4.09%, over one month by -2.93%, over three months by -1.12% and over the past year by +5.46%.
Is CHKP a buy, sell or hold?
- Strong Buy: 11
- Buy: 5
- Hold: 22
- Sell: 1
- Strong Sell: 0
What are the forecasts/targets for the CHKP price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 228.4 | 18.5% |
| Analysts Target Price | 228.4 | 18.5% |
| ValueRay Target Price | 211.4 | 9.7% |
CHKP Fundamental Data Overview January 05, 2026
P/E Forward = 16.8634
P/S = 7.2403
P/B = 6.3103
P/EG = 2.2174
Beta = 0.613
Revenue TTM = 2.68b USD
EBIT TTM = 909.7m USD
EBITDA TTM = 1.00b USD
Long Term Debt = unknown (none)
Short Term Debt = 8.80m USD (from shortTermDebt, last fiscal year)
Debt = 29.8m USD (from shortLongTermDebtTotal, last fiscal year)
Net Debt = -619.9m USD (from netDebt column, last quarter)
Enterprise Value = 18.00b USD (19.43b + Debt 29.8m - CCE 1.47b)
Interest Coverage Ratio = 505.4 (Ebit TTM 909.7m / Interest Expense TTM 1.80m)
EV/FCF = 15.27x (Enterprise Value 18.00b / FCF TTM 1.18b)
FCF Yield = 6.55% (FCF TTM 1.18b / Enterprise Value 18.00b)
FCF Margin = 43.91% (FCF TTM 1.18b / Revenue TTM 2.68b)
Net Margin = 37.62% (Net Income TTM 1.01b / Revenue TTM 2.68b)
Gross Margin = 85.97% ((Revenue TTM 2.68b - Cost of Revenue TTM 376.7m) / Revenue TTM)
Gross Margin QoQ = 85.34% (prev 84.52%)
Tobins Q-Ratio = 3.16 (Enterprise Value 18.00b / Total Assets 5.70b)
Interest Expense / Debt = 6.04% (Interest Expense 1.80m / Debt 29.8m)
Taxrate = 13.00% (126.4m / 972.1m)
NOPAT = 791.4m (EBIT 909.7m * (1 - 13.00%))
Current Ratio = 1.19 (Total Current Assets 2.03b / Total Current Liabilities 1.71b)
Debt / Equity = 0.01 (Debt 29.8m / totalStockholderEquity, last quarter 3.08b)
Debt / EBITDA = -0.62 (Net Debt -619.9m / EBITDA 1.00b)
Debt / FCF = -0.53 (Net Debt -619.9m / FCF TTM 1.18b)
Total Stockholder Equity = 2.86b (last 4 quarters mean from totalStockholderEquity)
RoA = 18.01% (Net Income 1.01b / Total Assets 5.70b)
RoE = 35.27% (Net Income TTM 1.01b / Total Stockholder Equity 2.86b)
RoCE = 22.82% (EBIT 909.7m / Capital Employed (Total Assets 5.70b - Current Liab 1.71b))
RoIC = 27.64% (NOPAT 791.4m / Invested Capital 2.86b)
WACC = 8.06% (E(19.43b)/V(19.46b) * Re(8.06%) + D(29.8m)/V(19.46b) * Rd(6.04%) * (1-Tc(0.13)))
Discount Rate = 8.06% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -1.52%
[DCF Debug] Terminal Value 77.32% ; FCFF base≈1.12b ; Y1≈1.08b ; Y5≈1.06b
Fair Price DCF = 178.3 (EV 18.52b - Net Debt -619.9m = Equity 19.14b / Shares 107.4m; r=8.06% [WACC]; 5y FCF grow -4.96% → 2.90% )
EPS Correlation: 69.90 | EPS CAGR: 16.11% | SUE: 4.0 | # QB: 1
Revenue Correlation: 78.00 | Revenue CAGR: 3.33% | SUE: 2.46 | # QB: 2
EPS next Quarter (2026-03-31): EPS=2.37 | Chg30d=-0.006 | Revisions Net=-2 | Analysts=29
EPS next Year (2026-12-31): EPS=10.56 | Chg30d=-0.004 | Revisions Net=+1 | Growth EPS=-6.3% | Growth Revenue=+6.1%
Additional Sources for CHKP Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle